Mauro Galeazzi
Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte · Siena University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mauro Galeazzi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:34 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03100253 · Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationMario Negri Institute for Pharmacological Research · terminated · Rheumatoid Arthritis · principal investigator
- Ph1NCT02076659 · Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis PatientsPhilogen S.p.A. · completed · Rheumatoid Arthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:34 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.Arthritis Rheum · 2002758 citationsRCR 19.6
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.Ann Rheum Dis · 2010350 citationsRCR 11.3
- Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.Arthritis Rheum · 2004295 citationsRCR 8.1
- Long-term i.v. Ig treatment in systemic lupus erythematosus.Clin Exp Rheumatol · 199478 citationsRCR 3.3
- 64 citationsRCR 1.7
- Short- and long-term effects of spa therapy in knee osteoarthritis.Am J Phys Med Rehabil · 201062 citationsRCR 2.3
- One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial.Int J Biometeorol · 201559 citationsRCR 3.4
- Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.Scand J Rheumatol · 199957 citationsRCR 2.1
- Efficacy of balneotherapy on pain, function and quality of life in patients with osteoarthritis of the knee.Int J Biometeorol · 201250 citationsRCR 2.5
- Short- and long-term effects of mud-bath treatment on hand osteoarthritis: a randomized clinical trial.Int J Biometeorol · 201448 citationsRCR 2.6